These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 22080481)

  • 21. [Paradoxical reactions and responses during antibiotic treatment for Mycobacterium ulcerans infection (Buruli ulcer). Four cases from French Guiana].
    Sambourg E; Dufour J; Edouard S; Morris A; Mosnier E; Reynaud Y; Sainte-Marie D; Nacher M; Guégan JF; Couppié P
    Ann Dermatol Venereol; 2014; 141(6-7):413-8. PubMed ID: 24951139
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Short report: edematous Mycobacterium ulcerans infection (Buruli ulcer) on the face: a case report.
    Phanzu DM; Ablordey A; Imposo DB; Lefevre L; Mahema RL; Suykerbuyk P; Meyers WM; Portaels F
    Am J Trop Med Hyg; 2007 Dec; 77(6):1099-102. PubMed ID: 18165530
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Shortening Buruli Ulcer Treatment with Combination Therapy Targeting the Respiratory Chain and Exploiting Mycobacterium ulcerans Gene Decay.
    Converse PJ; Almeida DV; Tyagi S; Xu J; Nuermberger EL
    Antimicrob Agents Chemother; 2019 Jul; 63(7):. PubMed ID: 31036687
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Compliance with antimicrobial therapy for buruli ulcer.
    Klis S; Kingma R; Tuah W; Stienstra Y; van der Werf TS
    Antimicrob Agents Chemother; 2014 Oct; 58(10):6340. PubMed ID: 25225342
    [No Abstract]   [Full Text] [Related]  

  • 25. Chemotherapy-associated changes of histopathological features of Mycobacterium ulcerans lesions in a Buruli ulcer mouse model.
    Ruf MT; Schütte D; Chauffour A; Jarlier V; Ji B; Pluschke G
    Antimicrob Agents Chemother; 2012 Feb; 56(2):687-96. PubMed ID: 22143518
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Buruli ulcer in West Africa: strategies for early detection and treatment in the antibiotic era.
    Webb BJ; Hauck FR; Houp E; Portaels F
    East Afr J Public Health; 2009 Aug; 6(2):144-7. PubMed ID: 20000019
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [A Papua New Guinean with three foot ulcers].
    Coenders A; Verregghen M; Baerends EP
    Ned Tijdschr Geneeskd; 2018; 162():D2295. PubMed ID: 29372678
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Secondary Buruli ulcer skin lesions emerging several months after completion of chemotherapy: paradoxical reaction or evidence for immune protection?
    Ruf MT; Chauty A; Adeye A; Ardant MF; Koussemou H; Johnson RC; Pluschke G
    PLoS Negl Trop Dis; 2011 Aug; 5(8):e1252. PubMed ID: 21829740
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Buruli ulcer caused by "Mycobacterium ulcerans subsp. shinshuense".
    Watanabe T; Ohkusu K; Nakanaga K; Ishii N; Nakashima K; Shindo M; Yoshida Y; Yamamoto O
    Eur J Dermatol; 2010; 20(6):809-10. PubMed ID: 20822972
    [No Abstract]   [Full Text] [Related]  

  • 30. Reply to "compliance with antimicrobial therapy for buruli ulcer".
    Phillips RO; Sarfo FS; Abass MK; Frimpong M; Ampadu E; Forson M; Amoako YA; Thompson W; Asiedu K; Wansbrough-Jones M
    Antimicrob Agents Chemother; 2014 Oct; 58(10):6341. PubMed ID: 25225343
    [No Abstract]   [Full Text] [Related]  

  • 31. [Comparison of inhibitory effect of rifalazil and rifampicin against Mycobacterium ulcerans infection induced in mice].
    Nakanaga K; Saito H; Ishii N; Goto M
    Kekkaku; 2004 May; 79(5):333-9. PubMed ID: 15211873
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Buruli ulcer. A disabling infection.
    Prescrire Int; 2010 Nov; 19(110):261-2. PubMed ID: 21284361
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Should antibiotics be given for Buruli ulcer?
    Johnson PD
    Lancet; 2010 Feb; 375(9715):618-9. PubMed ID: 20137806
    [No Abstract]   [Full Text] [Related]  

  • 34. Buruli ulcer in traveler from Suriname, South America, to the Netherlands.
    Faber WR; de Jong B; de Vries HJ; Zeegelaar JE; Portaels F
    Emerg Infect Dis; 2015 Mar; 21(3):497-9. PubMed ID: 25695367
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical efficacy of combination of rifampin and streptomycin for treatment of Mycobacterium ulcerans disease.
    Sarfo FS; Phillips R; Asiedu K; Ampadu E; Bobi N; Adentwe E; Lartey A; Tetteh I; Wansbrough-Jones M
    Antimicrob Agents Chemother; 2010 Sep; 54(9):3678-85. PubMed ID: 20566765
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Buruli ulcer: Advances in understanding Mycobacterium ulcerans infection.
    Walsh DS; Portaels F; Meyers WM
    Dermatol Clin; 2011 Jan; 29(1):1-8. PubMed ID: 21095521
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Histopathological examination of Buruli ulcer (Mycobacterium ulcerans disease) in surgically removed skin].
    Wakai S; Yajima M
    Nihon Hansenbyo Gakkai Zasshi; 2011 Sep; 80(3):269-74. PubMed ID: 21941833
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical outcomes of Ghanaian Buruli ulcer patients who defaulted from antimicrobial therapy.
    Klis S; Kingma RA; Tuah W; van der Werf TS; Stienstra Y
    Trop Med Int Health; 2016 Sep; 21(9):1191-6. PubMed ID: 27456068
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    Chamseddine S; Hindy JR; Haddad SF; Kanj SS
    BMJ Case Rep; 2022 Aug; 15(8):. PubMed ID: 35944937
    [No Abstract]   [Full Text] [Related]  

  • 40. The use of ozone therapy in Buruli ulcer had an excellent outcome.
    Bertolotti A; Izzo A; Grigolato PG; Iabichella ML
    BMJ Case Rep; 2013 Jan; 2013():. PubMed ID: 23376670
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.